The interaction between programmed cell death protein (PD-1) and programmed cell death ligand (PD-L1) inhibited T cell activity and the release of IFN-γ and IL-2, which produced a temporary immunosuppressive signal to reduce anti-tumor response ability (Gao et al., 2009). Here, IL2 is linked to neoplasm.